Ameriprise Financial Inc. Acquires 7,922 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Ameriprise Financial Inc. lifted its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 4.3% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 193,702 shares of the company’s stock after purchasing an additional 7,922 shares during the quarter. Ameriprise Financial Inc. owned about 0.11% of Option Care Health worth $4,494,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of the business. Cornerstone Investment Partners LLC lifted its stake in Option Care Health by 3.6% in the fourth quarter. Cornerstone Investment Partners LLC now owns 9,544 shares of the company’s stock valued at $221,000 after buying an additional 333 shares in the last quarter. UMB Bank n.a. raised its holdings in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after acquiring an additional 346 shares during the period. Assetmark Inc. raised its holdings in shares of Option Care Health by 2.0% during the fourth quarter. Assetmark Inc. now owns 24,976 shares of the company’s stock worth $579,000 after acquiring an additional 487 shares during the period. Pacer Advisors Inc. lifted its position in Option Care Health by 2.2% in the 4th quarter. Pacer Advisors Inc. now owns 25,483 shares of the company’s stock valued at $591,000 after acquiring an additional 537 shares in the last quarter. Finally, Blue Trust Inc. boosted its stake in Option Care Health by 16.9% in the 4th quarter. Blue Trust Inc. now owns 4,703 shares of the company’s stock worth $109,000 after purchasing an additional 681 shares during the period. 98.05% of the stock is owned by institutional investors.

Insider Activity

In related news, insider Michael Bavaro sold 30,996 shares of the stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 0.64% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on the company. JPMorgan Chase & Co. lifted their price target on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research note on Thursday, March 6th. UBS Group upgraded Option Care Health from a “neutral” rating to a “buy” rating and increased their price objective for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. JMP Securities restated a “market outperform” rating and issued a $36.00 target price on shares of Option Care Health in a research note on Tuesday, April 22nd. Finally, Barrington Research reaffirmed an “outperform” rating and set a $38.00 price target on shares of Option Care Health in a research report on Wednesday, April 30th. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company’s stock. According to data from MarketBeat, Option Care Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $35.50.

Option Care Health Trading Down 1.9%

NASDAQ OPCH opened at $31.41 on Monday. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The stock has a 50 day moving average of $32.99 and a 200-day moving average of $29.39. The company has a market cap of $5.14 billion, a PE ratio of 26.39, a PEG ratio of 2.30 and a beta of 0.76.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings results on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, beating analysts’ consensus estimates of $0.36 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to analysts’ expectations of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The company’s revenue for the quarter was up 16.3% compared to the same quarter last year. During the same quarter last year, the company posted $0.26 earnings per share. On average, equities research analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.